Skip to main content

Editorial Board

Editorial Board Members

Fowzan Alkuraya, MD, King Faisal Specialist Hospital and Research Center, Saudi Arabia
Patrick Aloy, PhD, Institute for Research in Biomedicine (IRB Barcelona), Spain
Andrew Beggs, PhD, University of Birmingham, UK
Jian Carrot-Zhang, PhD, Memorial Sloan Kettering Cancer Center, USA
Nicholas Croucher, PhD, Imperial College London, UK
Noel de Miranda, PhD, Leiden University Medical Center, Netherlands
Aaron Diaz, PhD, University of California, San Francisco, USA
Charis Eng, MD, PhD, Cleveland Clinic, USA
Greg Gibson, PhD, Georgia Institute of Technology, USA
Leng Han, PhD, Texas A&M University, USA
Winston Hide, PhD, Beth Israel Deaconess Medical Center/Harvard Medical School, USA
Francesco Iorio, PhD​​​​​​​, Human Technopole, Italy
Peter Robinson, MD, The Jackson Laboratory for Genomic Medicine, USA
Matthias Schwab, Dr. med.​​​​​​​, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, and Department of Clinical Pharmacology, University Hospital Tuebingen, Germany
Peter Sims, PhD​​​​​​​, Columbia University, USA
Nicola Waddell, PhD, QIMR Berghofer Medical Research Institute, Australia
Editorial Advisors

Russ Altman, Stanford University, USA

Charles Auffray, Centre National de la Recherche Scientifique, France

Alberto Bardelli, University of Torino and Candiolo Cancer Institute, Italy

Stephan Beck, University College London, UK

Mikael Benson, Linköping University Hospital, Sweden

Juergen Borlak, Hannover Medical School, Germany

Carl Borrebaeck, Lund University, Sweden

Atul Butte, UCSF School of Medicine, USA

Anne-Lise Børresen-Dale, University of Oslo, Norway

George Calin, MD Anderson Cancer Center, USA

Timothy Caulfield, University of Alberta, Canada

Richard Christopherson, University of Sydney, Australia

Angus Clarke, Cardiff University, UK

Ann Daly, Newcastle University, UK

Paul Edwards, Cambridge University, UK

Gary Gibbons, National Heart, Lung, and Blood Institute, USA

Takashi Gojobori, National Institute of Genetics, Japan

Julian Griffin, University of Cambridge, UK

Sean Grimmond, University of Melbourne, Australia

David Gurwitz, Tel-Aviv University, Israel

Martin Hibberd, London School of Hygiene and Tropical Medicine, UK

Robert Holt, British Columbia Cancer Agency, Canada

Leroy Hood, Institute for Systems Biology, USA

Matthew Hurles, Wellcome Trust Sanger Institute, UK

Curtis Huttenhower,  Harvard T.H Chan School of Public Health, USA

Rima Kaddurah-Daouk, Duke University, USA

Jane Kaye, University of Oxford, UK

Muin Khoury, Centers for Disease Control and Prevention, USA

Bartha Maria Knoppers, McGill University, Canada

Isaac Kohane, Harvard Medical School, USA

Razelle Kurzrock, University of California San Diego School of Medicine and WIN Consortium for Personalized Cancer Therapy 

Nuria Lopez-Bigas, University Pompeu Fabra, Spain

Jeantine Lunshof, VU University Amsterdam, Netherlands

James Lupski, Baylor College of Medicine, USA

Amy McGuire, Baylor College of Medicine, USA

Aleksandar Milosavljevic, Baylor College of Medicine, USA

Valerie Mizrahi, University of Cape Town, South Africa

Yves Moreau, University of Leuven, Belgium

Jeremy Nicholson, Imperial College London, UK

Stuart Orkin, Harvard Medical School, USA

Michael Owen, Cardiff University, UK

Munir Pirmohamed, University of Liverpool, UK

Heidi Rehm, Massachusetts General Hospital and Broad Institute of MIT and Harvard

Alexandre Reymond, University of Lausanne, Switzerland

H Hilger Ropers, Max-Planck Institute for Molecular Genetics, Germany

Charles Rotimi, National Institutes of Health, UK

Steven Rozen, Duke-NUS Graduate Medical School, Singapore

Stephen Scherer, The Hospital for Sick Children, Canada

Nicholas Schork, Craig Venter Research Institute, UK

Jay Shendure, University of Washington, USA

Richard Smith, Pacific Northwest National Laboratory, USA

Michael Snyder, Stanford University, USA

Nicole Soranzo, Wellcome Trust Sanger Institute, UK

Michael Speicher, Medical University of Graz, Austria

Barry Taylor, Memorial Sloan Kettering Cancer Center, USA

Toshikazu Ushijima, National Cancer Center Research Institute, Japan

Joris Veltman, University of Newcastle, UK

Marc Vidal, Dana-Farber Cancer Institute, USA

Peter Visscher, University of Queensland, Australia

Scott Weiss, Brigham and Women's Hospital, USA

Zemin Zhang, Peking University, China

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2023 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    185 days submission to accept (Median)

    2023 Usage 
    4,916 Altmetric mentions

  • Peer Review Taxonomy

    This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here

    The following summary describes the peer review process for this journal:

    • Identity transparency: Single anonymized
    • Reviewer interacts with: Editor
    • Review information published: None

    We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.